Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Primary osteoporosis in postmenopausal women.

Ji MX, Yu Q.

Chronic Dis Transl Med. 2015 Mar 21;1(1):9-13. doi: 10.1016/j.cdtm.2015.02.006. eCollection 2015 Mar. Review. No abstract available.

2.

Risk of Fracture in Women with Sarcopenia, Low Bone Mass, or Both.

Harris R, Chang Y, Beavers K, Laddu-Patel D, Bea J, Johnson K, LeBoff M, Womack C, Wallace R, Li W, Crandall C, Cauley J.

J Am Geriatr Soc. 2017 Dec;65(12):2673-2678. doi: 10.1111/jgs.15050. Epub 2017 Sep 27.

PMID:
28960230
3.

Periodontal treatment outcomes in post menopausal women receiving hormone replacement therapy.

Cekici A, Baser U, Isik G, Akhan SE, Issever H, Onan U.

J Istanb Univ Fac Dent. 2015 Oct 21;49(3):39-44. doi: 10.17096/jiufd.61637. eCollection 2015.

4.

Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization.

Prior JC, Seifert-Klauss VR, Giustini D, Adachi JD, Kalyan S, Goshtasebi A.

J Musculoskelet Neuronal Interact. 2017 Sep 1;17(3):146-154.

5.

Trends in Female Breast Cancer by Age Group in the Chiang Mai Population

Sripan P, Sriplung H, Pongnikorn D, Virani Sh, Bilheem S, Chaisaengkhaum U, Maneesai P, Waisri N, Hanpragopsuk Ch, Tansiri P, Khamsan V, Poungsombat M, Mawoot A, Chitapanarux I.

Asian Pac J Cancer Prev. 2017 May 1;18(5):1411-1416.

6.

Long-term supplementation with young coconut juice does not prevent bone loss but rather alleviates body weight gain in ovariectomized rats.

Matsushita H, Minami A, Kanazawa H, Suzuki T, Subhadhirasakul S, Watanabe K, Wakatsuki A.

Biomed Rep. 2017 May;6(5):585-591. doi: 10.3892/br.2017.883. Epub 2017 Apr 5.

7.

Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial.

Yoon BK, Lee DY, Park MC, Cho SH, Park HM, Choi YM.

J Korean Med Sci. 2017 Jun;32(6):992-998. doi: 10.3346/jkms.2017.32.6.992.

8.

Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women.

Wang Y, Wactawski-Wende J, Sucheston-Campbell LE, Preus L, Hovey KM, Nie J, Jackson RD, Handelman SK, Nassir R, Crandall CJ, Ochs-Balcom HM.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):1908-1916. doi: 10.1210/jc.2016-2936.

PMID:
28324062
9.

How can gynaecologists cope with the silent killer - osteoporosis?

Szamatowicz M.

Prz Menopauzalny. 2016 Dec;15(4):189-192. doi: 10.5114/pm.2016.65682. Epub 2017 Feb 8.

10.

Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals.

Oliveira D, Hassumi JS, Gomes-Ferreira PH, Polo TO, Ferreira GR, Faverani LP, Okamoto R.

J Appl Oral Sci. 2017 Jan-Feb;25(1):42-52. doi: 10.1590/1678-77572016-0165.

11.

New horizons in treatment of osteoporosis.

Tabatabaei-Malazy O, Salari P, Khashayar P, Larijani B.

Daru. 2017 Feb 7;25(1):2. doi: 10.1186/s40199-017-0167-z. Review.

12.

Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.

Sullivan SD, Lehman A, Nathan NK, Thomson CA, Howard BV.

Menopause. 2017 Apr;24(4):371-378. doi: 10.1097/GME.0000000000000775.

PMID:
27801706
13.

Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends.

Bolton JL.

Chem Res Toxicol. 2016 Oct 17;29(10):1583-1590. Epub 2016 Sep 26. Review.

14.

Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60-64 Years: A British Birth Cohort.

Kuh D, Muthuri S, Cooper R, Moore A, Mackinnon K, Cooper C, Adams JE, Hardy R, Ward KA.

J Clin Endocrinol Metab. 2016 Oct;101(10):3827-3837. Epub 2016 Jul 29.

15.

Surgical prevention of femoral neck fractures in elderly osteoporotic patients. A literature review.

Chiarello E, Tedesco G, Cadossi M, Capra P, Terrando S, Miti A, Giannini S.

Clin Cases Miner Bone Metab. 2016 Jan-Apr;13(1):42-5. doi: 10.11138/ccmbm/2016.13.1.042. Epub 2016 May 11. Review.

16.

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.

Vescini F, Attanasio R, Balestrieri A, Bandeira F, Bonadonna S, Camozzi V, Cassibba S, Cesareo R, Chiodini I, Francucci CM, Gianotti L, Grimaldi F, Guglielmi R, Madeo B, Marcocci C, Palermo A, Scillitani A, Vignali E, Rochira V, Zini M.

J Endocrinol Invest. 2016 Jul;39(7):807-34. doi: 10.1007/s40618-016-0434-8. Epub 2016 Mar 11.

17.

Changes in Nonosteoporotic Bone Density and Subsequent Fractures in Women.

Pfister AK, Welch CA, John M, Emmett MK.

South Med J. 2016 Feb;109(2):118-23. doi: 10.14423/SMJ.0000000000000410.

18.

Oral contraceptive use and fracture risk around the menopausal transition.

Scholes D, LaCroix AZ, Hubbard RA, Ichikawa LE, Spangler L, Operskalski BH, Gell N, Ott SM.

Menopause. 2016 Feb;23(2):166-74. doi: 10.1097/GME.0000000000000595.

19.

Age and Long-Term Hormone Treatment Effects on the Ultrastructural Morphology of the Median Eminence of Female Rhesus Macaques.

Naugle MM, Lozano SA, Guarraci FA, Lindsey LF, Kim JE, Morrison JH, Janssen WG, Yin W, Gore AC.

Neuroendocrinology. 2016;103(6):650-64. doi: 10.1159/000442015. Epub 2015 Nov 5.

20.

We need a break: Bisphosphonates.

Jaiman A, Sabat D, Arora S, Hafez MA.

J Clin Orthop Trauma. 2013 Mar;4(1):11-4. doi: 10.1016/j.jcot.2013.01.010. Epub 2013 Feb 6. Review.

Supplemental Content

Support Center